Asthma, COPD: per inhalation contains budesonide(mcg)/formoterol fumarate(mcg) 80/4.5 or 160/4.5.
2 inhalations twice daily. Not to use more than 4 inhalations/day of either strength.
Patients who are receiving low-medium dose inhaled corticosteroid may be started on lower strength combination while those receiving medium-high dose inhaled corticosteroid may be started on higher strength combination.
Patients who are not adequately controlled on the lower strength combination may convert to the higher strength combination after 1-2 week of treatment.
Adverse drug reactions
: headache, nasopharyngitis, upper respiratory tract infections, stomach discomfort, vomiting, oral candidiasis, back pain, nasal congestion, sinusitis.
Indications in palliative care
: reversible and irreversible airways obstruction, stridor, lymphangitis carcinomatosa, radiation pneumonitis, cough after insertion of bronchial stent.
Adapted from CIMS Drug Information System. Internet. Accessed on January 10, 2016.